EDIT - Genomic Health Is Positioned For Strong Returns
Genomic Health (GHDX) is a top provider of genomic-based diagnostic tests that help optimize cancer care, including addressing the overtreatment of the disease, one of the greatest issues in healthcare today. Genomic Health offers its tissue-based invasive breast, prostate, colon, and DCIS Oncotype DX tests as clinical laboratory services.
According to management, the company has prospective evidence from more than 63,000 patients demonstrating that the Oncotype DX Breast Recurrence Score test accurately predicts outcomes, and it calculates that access to Genomic Health tests that enables personalized treatment decision-making has saved the healthcare system